Reliance Medical Systems Now Offering Clients Leading Cardiac Risk Assessment Solution

The Woodlands, TX, November 02, 2012 --(PR.com)-- Industry leaders for innovative health technology, Reliance Medical Systems has recently announced that the company will now be selling the EndoPAT™ system directly to their clients across the medical field in the United States. The EndoPAT™ system is considered by medical professionals around the globe to be the next advancement in cardiac risk assessment solutions.

By integrating the EndoPAT™ system within their facilities, care providers can ensure that their patients have access to one of the best non-invasive cardiac risk assessment products on the market. One of the leading operational advantages for health care professionals in using this product is that tests only takes 15 minutes for medical assistants to administer. In addition, because the system is so easy-to-use, it doesn’t require extensive training and therefore medical teams can incorporate this diagnostic tool within their care facilities with seamless ease. Another benefit is that this system offers proven accurate results immediately. This means that patients don’t have to spend anxious days worrying about their potential health issues and exacerbating any issues they might have.

Professionals from across the medical industry have assessed this product and deemed it to be the leading method for measuring endothelial function in patients. There is now documented research based on EndoPAT™ that has yielded more than 290 articles in peer-reviewed journals and scientific abstracts. It’s the trusted solution for proactive cardiac risk assessment diagnosis and it’s now available through the team at Reliance Medical Systems.

To learn more about the EndoPAT™ system and any of the products available through Reliance Medical Systems, please visit the organization’s website at www.reliancmedical.com.